App-Quantinova.ai

Comparison Of Plasma Kallikrein Inhibition By The Endogenous C1-Inhibitor Versus DX-2930, a Monoclonal Antibody Inhibitor

Daniel J Sexton - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

Venous thrombosis

DX2930

Thrombus Development Processes Are Dependent On Endothelial Injuries: Examined By In Vivo Molecular Imaging

Koji Eto - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

ADAM28 Metalloprotease Domain Is Sufficient For Proteolytic Cleavage Of Von Willlebrand Factor

Hayley A. Hanby - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

thrombospondin-1

Gamma Prime Fibrinogen Does Not Cause Arterial Thrombosis

Bethany L Walton - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Inhibition Of Anti-b2GPI-Dependent Thrombus Enhancement In The Laser-Induced Thrombosis Model In Mice

Alexey Kolyada - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Normal Range Of Bleeding Scores For The ISTH-BAT: Adult and Pediatric Data From The Merging Project

Malak Elbatarny - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Severe Acquired Bleeding Tendency Secondary To An Anti-Thrombin Antibody In a Patient With Monoclonal Gammapathy Of Unknown Significance: Direct In Vivo evidence

Valerie Proulle - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

Bortezomib

A Two Centre Experience Of Use Of a Dual Virally Inactivated FVIII/VWF Product (Wilate) In Patients With Von Willebrand Disease

Paul A Batty - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Wilate

Outcomes In Adult Hemophilia and Von Willebrand Disease Patients Undergoing Surgical and Invasive Procedures

John C. Chapin - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

FVIII

Retrospective Study Of Incidence Of Thromboses In Chinese Versus African Americans With Multiple Myeloma

Radha Raghupathy - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Dexamethasone

The Risk Of Recurrence In Women With Venous Thromboembolism While Using Estrogens: A Prospective Observational Cohort Study

Paul A Kyrle - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

Estrogens

Biomarkers and Clinical Characteristics Of Patients With and Without DVT In The Intensive Care Unit (ICU)

Suman L. Sood - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

N/A

A Novel Assay For The Preferential Detection Of Pathogenic HIT Antibodies

Anand Padmanabhan - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Heparin

The Effectiveness Of 30-40 Mm Hg Compression Stockings To Treat Acute Leg Pain Associated With Proximal Deep Vein Thrombosis: Results From The Sox Randomized Controlled Trial

Susan R. Kahn - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

A Proteomics-Based Approach To Identifying Mechanisms Of Cancer-Associated Thrombosis: Potential Role For Immunoglobulins

Alok A. Khorana - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Venous thrombosis

Trypsin

The Role Of High Von Willebrand Factor and Low ADAMTS13 Levels In The Risk Of Venous Thromboembolism

Christiane Pereira Gouvea - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Gastroenterology (GU)

Venous thrombosis

FVIII

The Challenge Of Russells Viper Venom Time Interpretation For Lupus Anticoagulant Diagnosis: A Two-Year Retrospective Institutional Review

Geoffrey D. Wool - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Autoimmune (AI)

Venous thrombosis

N/A

Predictive Value Of Markers Of Fibrinolysis and Endothelial Dysfunction In The Post Thrombotic Syndrome: A Systematic Review

Anat Rabinovich - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Fibrinogen (IV)

Four-Factor Prothrombin Complex Concentrate (4-PCC) Effectively Reverses Edoxaban Induced Bleeding In a Rabbit Model Of Acute Injury

Eva Herzog - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Prothrombin complex

The Cost Analysis Of Aspirin Versus Low Molecular Weight Heparin For Thromboprophylaxis Following Total Hip Arthroplasty

Owen Chauhan - American Society of Hematology (ASH) , 2013

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

dalteparin Subcutaneous

Filters

7277 Abstracts